India Cancer Diagnostics and Therapeutics Market (2025-2031) | Value, Competitive Landscape, Trends, Companies, Growth, Analysis, Share, Segmentation, Forecast, Size & Revenue, Outlook, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 India Cancer Diagnostics and Therapeutics Market - Industry Life Cycle

3.4 India Cancer Diagnostics and Therapeutics Market - Porter's Five Forces

3.5 India Cancer Diagnostics and Therapeutics Market Revenues & Volume Share, By Diagnostic Test, 2021 & 2031F

3.6 India Cancer Diagnostics and Therapeutics Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing awareness about early cancer detection and treatment

4.2.3 Advancements in diagnostic technologies and therapies

4.2.4 Government initiatives to improve cancer care infrastructure

4.2.5 Rise in healthcare expenditure and insurance coverage

4.3 Market Restraints

4.3.1 High cost associated with cancer diagnostics and therapeutics

4.3.2 Limited access to advanced cancer treatments in rural areas

4.3.3 Regulatory challenges and approval processes for new therapies

4.3.4 Shortage of skilled healthcare professionals specializing in oncology

4.3.5 Stigma and cultural beliefs surrounding cancer leading to delayed diagnosis and treatment

6.1 India Cancer Diagnostics and Therapeutics Market, By Diagnostic Test

6.1.1 Overview and Analysis

6.1.2 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Diagnostic Test, 2021- 2031F

6.1.3 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Pap Smear Test, 2021- 2031F

6.1.4 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By HPV Test, 2021- 2031F

6.1.5 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Colposcopy, 2021- 2031F

6.1.6 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Biopsy and Endocervical Curettage, 2021- 2031F

6.1.7 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Other Diagnostic Tests, 2021- 2031F

6.2 India Cancer Diagnostics and Therapeutics Market, By Therapeutics

6.2.1 Overview and Analysis

6.2.2 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Avastin (Bevacizumab), 2021- 2031F

6.2.3 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Blenoxane (Bleomycin), 2021- 2031F

6.2.4 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Hycamtin (Topotecan Hydrochloride), 2021- 2031F

6.2.5 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Gemcitabine-Cisplatin, 2021- 2031F

6.2.6 India Cancer Diagnostics and Therapeutics Market Revenues & Volume, By Vaccines, 2021- 2031F

7.1 India Cancer Diagnostics and Therapeutics Market Export to Major Countries

7.2 India Cancer Diagnostics and Therapeutics Market Imports from Major Countries

8.1 Adoption rate of advanced diagnostic technologies

8.2 Percentage of cancer patients diagnosed at early stages

8.3 Investment in research and development of new cancer therapies

8.4 Number of cancer treatment centers and facilities in India

8.5 Patient survival rates for different types of cancer

9.1 India Cancer Diagnostics and Therapeutics Market Opportunity Assessment, By Diagnostic Test, 2021 & 2031F

9.2 India Cancer Diagnostics and Therapeutics Market Opportunity Assessment, By Therapeutics, 2021 & 2031F

10.1 India Cancer Diagnostics and Therapeutics Market Revenue Share, By Companies, 2024

10.2 India Cancer Diagnostics and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters